NEW YORK, Dec 4 – Zyomyx and Cambridge Antibody Technology have entered into an agreement to jointly develop high-density protein chips, Zyomyx announced Monday.

Zyomyx will develop, manufacture and market the chips using its proprietary surface chemistry methods and Cambridge Antibody Technology’s library of antibodies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.